SCHEMBL4664162

SCHEMBL4664162

Cn1ccc(CCC(N)=O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 2/20 0.40
NR1I2 O75469 1/20 0.40
KCNH2 Q12809 1/20 0.40
EPHX2 P34913 1/20 0.40
CAPN1 P07384 1/20 0.40
LMNA P02545 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
NAMPT P43490 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
PDK1 Q15118 1/20 0.35
TSHR P16473 1/20 0.35
GLS O94925 1/20 0.34
KEAP1 Q14145 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2629336 0.84 NR1H4 (0.44) EPHX2LMNAKDM4EALDH1A1HTT
SCHEMBL2983517 0.81 GLS (0.41) GRM2NR1I2KCNH2EPHX2LMNA
SCHEMBL20818690 0.79 TSHR (0.43) EPHX2LMNAKDM4EALDH1A1HTT
SCHEMBL21576905 0.79 EPHX2 (0.38) GRM2NR1I2KCNH2EPHX2LMNA
SCHEMBL21246185 0.77 NAMPT (0.46) GRM2EPHX2LMNAKDM4EALDH1A1
SCHEMBL25056422 0.77 LMNA (0.49) LMNAKDM4EALDH1A1TSHRNPC1
SCHEMBL22572072 0.76 EPHX2 (0.35) GRM2NR1I2KCNH2EPHX2LMNA
SCHEMBL14210027 0.76 KEAP1 (0.51) GRM2NR1I2KCNH2CAPN1LMNA
SCHEMBL1066313 0.74 HDAC1 (0.39) KDM4ESMN1; SMN2RAB9A
Bromide SCHEMBL28241983 0.73 EPHX2 (0.44) GRM2NR1I2KCNH2EPHX2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007717-A1 NOVEL SULFONAMIDE COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2008-12-31 EP claimed
WO-2007116374-A1 NOVEL SULFONAMIDE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2007-10-18 WO claimed
EP-3793565-B1 MCL-1 INHIBITORS GILEAD SCIENCES INC (US) 2022-01-05 EP disclosed
EP-2007717-A1 NOVEL SULFONAMIDE COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2008-12-31 EP disclosed
WO-2007116374-A1 NOVEL SULFONAMIDE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2007-10-18 WO disclosed